Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARADIGM CORP. ARDM -- Ignore unavailable to you. Want to Upgrade?

To: Gregg Soster who wrote (17)	6/17/1998 8:16:00 PM
From: Marvin Frank	Read Replies (1) \| Respond to of 255

Dear Richard, The recent WSJ article about Pfizer and INHL was responsible for drop in ARDM but remember ARDM is still lower priced stock. It's a hard call as to which is more advanced in the insulin administration race but news earlier this month seemed to indicate that ARDM was the leader. Either way, I feel the technology is great and either company will be able to utilize inhalation therapy for many other drugs. There are multiple meds that cannot be given orally and can possibly be given this way, as vitamin B12 and many hormones, of which insulin is included.